NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03/10/2026
Back to search
Official data from USPTO
CARNA BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CARNA BIOSCIENCES
ST13
US500000079008908Class
1, 5, 42
Filing
79008908
Registration
3071237
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
03/11/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
01/04/2005
Registration date
03/21/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2026
Last transaction
03/11/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
JP
Examiner
KHOURI, SANI PHILIPPE
Current location
Historical data usage
Holders and representatives
Holders
CARNA BIOSCIENCES, INC.
Representatives
Michael S. Hargis Stites & Harbison, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Peptide for in vitro research use and for scientific and medical research; polypeptide for in vitro research use and for scientific and medical research; protein for in vitro research use and for scientific and medical research; chemical reagents for non-medical purposes and non-veterinary purposes; and ferments for in vitro research use and for scientific and medical research
Class 5
Chemical reagents for medical or veterinary purposes ; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes; diagnostic preparations for medical purposes; drugs for medical purposes for the treatment of cancerinflammationdermal diseasesheart diseasesrespiratory diseases and disordersgastrointestinal diseasesinfectious diseasesbone diseasescirculatory diseasecerebral diseases and articular rheumatism; medicines for human purposes for the treatment of cancerinflammationdermal diseasesheart diseasesrespiratory diseases and disordersgastrointestinal diseasesinfectious diseasesbone diseasescirculatory diseasecerebral diseases and articular rheumatism; organotherapy preparations for the treatment of cancerinflammationdermal diseasesheart diseasesrespiratory diseases and disordersgastrointestinal diseasesinfectious diseasesbone diseasescirculatory diseasecerebral diseases and articular rheumatism; pharmaceutical preparations for the treatment of cancerinflammationdermal diseasesheart diseasesrespiratory diseases and disordersgastrointestinal diseasesinfectious diseasesbone diseasescirculatory diseasecerebral diseases and articular rheumatism; serotherapeutic medicines for the treatment of cancerinflammationdermal diseasesheart diseasesrespiratory diseases and disordersgastrointestinal diseasesinfectious diseasesbone diseasescirculatory diseasecerebral diseases and articular rheumatism; pharmaceutical preparations for skin care; biological preparations for medical purposes; and ferments for medical or veterinary use
Class 42
Bacteriological research; biological research; chemical analysis; chemical research; chemistry services; cosmetic research; mechanical research; calibration measuring; and biological or chemical research consultancy
Publications
History of USPTO decisions and trademark events.
56 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
03/10/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/09/2026
ES71
TEAS SECTION 71 RECEIVED
11/10/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/27/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/27/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
10/27/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/27/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/27/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/27/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/27/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/21/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/10/2024
RINX
USPTO CORRECTION PROCESSED BY IB
01/17/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/13/2017
XXCR
GENERIC MADRID TRANSACTION CREATED
09/13/2017
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
05/05/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/18/2017
XXCR
GENERIC MADRID TRANSACTION CREATED
01/18/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/04/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
04/04/2016
71AG
REGISTERED-SEC.71 ACCEPTED
04/04/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/01/2016
ES71
TEAS SECTION 71 RECEIVED
01/13/2016
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/21/2015
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/19/2015
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/12/2015
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
03/28/2014
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/13/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/16/2013
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
03/12/2013
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/12/2012
71AG
REGISTERED-SEC.71 ACCEPTED
06/12/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/12/2012
ES71
TEAS SECTION 71 RECEIVED
03/16/2012
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/02/2007
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
12/14/2006
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/24/2006
FIMP
FINAL DISPOSITION PROCESSED
10/24/2006
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/19/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
03/21/2006
PUBO
PUBLISHED FOR OPPOSITION
12/27/2005
NPUB
NOTICE OF PUBLICATION
12/07/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/08/2005
ALIE
ASSIGNED TO LIE
11/04/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
10/19/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2005
PAPER RECEIVED
10/05/2005
RFNT
REFUSAL PROCESSED BY IB
08/25/2005
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/09/2005
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/09/2005
CNRT
NON-FINAL ACTION WRITTEN
08/08/2005
DOCK
ASSIGNED TO EXAMINER
08/04/2005
NWAP
NEW APPLICATION ENTERED
03/25/2005
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/24/2005
Continuous trademark protection
Get notified about every new filing that threatens CARNA BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.